BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35283452)

  • 21. Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis.
    Agbor-Enoh S; Jackson AM; Tunc I; Berry GJ; Cochrane A; Grimm D; Davis A; Shah P; Brown AW; Wang Y; Timofte I; Shah P; Gorham S; Wylie J; Goodwin N; Jang MK; Marishta A; Bhatti K; Fideli U; Yang Y; Luikart H; Cao Z; Pirooznia M; Zhu J; Marboe C; Iacono A; Nathan SD; Orens J; Valantine HA; Khush K
    J Heart Lung Transplant; 2018 Jul; 37(7):925-932. PubMed ID: 29500138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding Donor-derived Cell-free DNA in Kidney Transplantation: An Overview and Case-based Guide for Clinicians.
    Graver AS; Lee D; Power DA; Whitlam JB
    Transplantation; 2023 Aug; 107(8):1675-1686. PubMed ID: 36579675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of Donor-Derived Cell-Free DNA at the Early Phase After Pediatric Kidney Transplantation: A Prospective Cohort Study.
    Nie W; Su X; Liu L; Li J; Fu Q; Li X; Wu C; Wang J; Deng R; Chen E; Yang S; Li S; Zhang H; Wang C
    Front Med (Lausanne); 2021; 8():814517. PubMed ID: 35071284
    [No Abstract]   [Full Text] [Related]  

  • 24. Monitoring of plasma circulating donor DNA reflects cardiac graft injury: Report of two cases.
    Dlouha D; Huckova P; Rohlova E; Vymetalova J; Novakova S; Hubacek JA
    Biomed Rep; 2024 Mar; 20(3):50. PubMed ID: 38357233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction.
    Quaglia M; Merlotti G; Guglielmetti G; Castellano G; Cantaluppi V
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of graft-derived cell-free DNA as a novel biomarker to predict allograft function after kidney transplantation.
    Di W; Ran Q; Yang H; Lu J; Hou Y; Wang X; He J; Wei L
    Int J Urol; 2021 Oct; 28(10):1019-1025. PubMed ID: 34229363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study.
    Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S
    J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating Long Noncoding RNA LNC-EPHA6 Associates with Acute Rejection after Kidney Transplantation.
    Groeneweg KE; Duijs JMGJ; Florijn BW; van Kooten C; de Fijter JW; van Zonneveld AJ; Reinders MEJ; Bijkerk R
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation.
    Agbor-Enoh S; Wang Y; Tunc I; Jang MK; Davis A; De Vlaminck I; Luikart H; Shah PD; Timofte I; Brown AW; Marishta A; Bhatti K; Gorham S; Fideli U; Wylie J; Grimm D; Goodwin N; Yang Y; Patel K; Zhu J; Iacono A; Orens JB; Nathan SD; Marboe C; Berry GJ; Quake SR; Khush K; Valantine HA
    EBioMedicine; 2019 Feb; 40():541-553. PubMed ID: 30692045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch.
    Zou J; Duffy B; Slade M; Young AL; Steward N; Hachem R; Mohanakumar T
    Hum Immunol; 2017 Apr; 78(4):342-349. PubMed ID: 28267558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Noninvasive and Donor-independent Method Simultaneously Monitors Rejection and Infection in Patients With Organ Transplant.
    Zhou Y; Yang G; Liu H; Chen Y; Li X; Ge J; Wang X; Niu H; Dong W; Jiang T; Shi H; Peng L; Liu L
    Transplant Proc; 2019; 51(6):1699-1705. PubMed ID: 31399160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury.
    Bazemore K; Rohly M; Permpalung N; Yu K; Timofte I; Brown AW; Orens J; Iacono A; Nathan SD; Avery RK; Valantine H; Agbor-Enoh S; Shah PD
    J Heart Lung Transplant; 2021 Nov; 40(11):1454-1462. PubMed ID: 34344623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel urine cell-free DNA preservation solution and its application in kidney transplantation.
    Zhou Q; Liu F; Guo L; Chen R; Yuan X; Li C; Shu L; Liu H; Zhou Y; Wu Y; Shi H; Zhao H; Jiang T
    Nephrology (Carlton); 2021 Aug; 26(8):684-691. PubMed ID: 33866646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury.
    Beck J; Bierau S; Balzer S; Andag R; Kanzow P; Schmitz J; Gaedcke J; Moerer O; Slotta JE; Walson P; Kollmar O; Oellerich M; Schütz E
    Clin Chem; 2013 Dec; 59(12):1732-41. PubMed ID: 24061615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated cell-free DNA in respiratory viral infection and associated lung allograft dysfunction.
    Bazemore K; Permpalung N; Mathew J; Lemma M; Haile B; Avery R; Kong H; Jang MK; Andargie T; Gopinath S; Nathan SD; Aryal S; Orens J; Valantine H; Agbor-Enoh S; Shah P
    Am J Transplant; 2022 Nov; 22(11):2560-2570. PubMed ID: 35729715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of methods for donor-derived cell-free DNA quantification in plasma and urine from solid organ transplant recipients.
    Kueng N; Arcioni S; Sandberg F; Kuhn C; Banz V; Largiadèr CR; Sidler D; Amstutz U
    Front Genet; 2023; 14():1089830. PubMed ID: 36777723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A fast and simple method for detecting and quantifying donor-derived cell-free DNA in sera of solid organ transplant recipients as a biomarker for graft function.
    Adamek M; Opelz G; Klein K; Morath C; Tran TH
    Clin Chem Lab Med; 2016 Jul; 54(7):1147-55. PubMed ID: 26574891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating cell-free nucleosomes as biomarker for kidney transplant rejection: a pilot study.
    Verhoeven JGHP; Baan CC; Peeters AMA; Clahsen-van Groningen MC; Nieboer D; Herzog M; Eccleston M; Hesselink DA; Boer K
    Clin Epigenetics; 2021 Feb; 13(1):32. PubMed ID: 33573704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
    Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
    Front Immunol; 2020; 11():342. PubMed ID: 32184785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor-specific circulating cell free DNA as a noninvasive biomarker of graft injury in heart transplantation.
    Macher HC; García-Fernández N; Adsuar-Gómez A; Porras-López M; González-Calle A; Noval-Padillo J; Guerrero JM; Molinero P; Borrego-Domínguez JM; Herruzo-Avilés Á; Rubio A
    Clin Chim Acta; 2019 Aug; 495():590-597. PubMed ID: 31175849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.